Nemaura Medical, Inc. Common Stock
NMRD
NMRD was delisted on the 4th of January, 2024.
0 hedge funds and large institutions have $0 invested in Nemaura Medical, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $1.85K → $0 (-$1.85K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$1.68K |
| 2 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$174 |
NMRD Hedge Fund Activity: Q2 2024 in Review
0 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Nemaura Medical, Inc. Common Stock (NMRD) for Q2 2024, worth a combined $0 — down 100% from $1.85K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of NMRD and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was XTX Topco, exiting entirely with an estimated $1.68K sold.
- 0 institutional investors held Nemaura Medical, Inc. Common Stock (NMRD) as of Q2 2024, down from 2 in Q1 2024.
- Funds reported $0 of Nemaura Medical, Inc. Common Stock stock for Q2 2024, down 100% quarter-over-quarter.
- 0 funds opened new Nemaura Medical, Inc. Common Stock positions in Q2 2024 and 2 closed out, a net change of -2 holders.
- The largest Nemaura Medical, Inc. Common Stock seller in Q2 2024 was XTX Topco, an estimated $1.68K sold.
Based on aggregated 13F filings for Q2 2024.